Avendus Future Leaders Fund and SBI Life Insurance have collectively invested ₹300 crore in Aragen Life Sciences, acquiring a 2.5% stake in the company. This secondary deal, valuing Aragen at ₹12,200 crore, involved stake dilution by the Reddy family. The investment highlights the attractiveness of India's pharmaceutical sector as a global hub for outsourcing manufacturing and drug development research.
from Banking/Finance-Industry-Economic Times https://ift.tt/dLg3TQj
via IFTTT
No comments:
Post a Comment